{"id":"W2947422641","doi":"10.1016/s1665-2681(19)30843-9","title":"A phase 2 study of filibuvir in combination with pegylated IFN alfa and ribavirin for chronic HCV","year":2014,"lang":"en","type":"article","venue":"Annals of Hepatology","topic":"Hepatitis C virus research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"Pfizer","keywords":"Ribavirin; Medicine; Internal medicine; Gastroenterology; Nausea; Adverse effect; Placebo; Pegylated interferon; Clinical endpoint; Hepatitis C virus; Hepatitis C; Randomized controlled trial; Immunology; Virus","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002616806,0.002088607,0.002314219,0.0006915017,0.000566289,0.001004863,0.001180191,0.001811087,0.005141045],"category_scores_gemma":[0.001121799,0.00104103,0.001533385,0.0004241639,0.0009591965,0.001065344,0.0004125101,0.003134572,0.001030097],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009220233,"about_ca_system_score_gemma":0.001667288,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001037884,"about_ca_topic_score_gemma":0.001864513,"domain_scores_codex":[0.9992649,0.0003691208,0.00004032084,0.0001106898,0.00007601258,0.0001390576],"domain_scores_gemma":[0.9992483,0.0001466125,0.0001497012,0.00005998963,0.00005426562,0.0003409869],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8261311,0.1042564,0.002108667,0.0005711311,0.0009550446,0.0001758635,0.0001771864,0.0009593162,0.01706599,0.0001588217,0.001258559,0.0461819],"study_design_scores_gemma":[0.7684895,0.2267755,0.00226232,0.00001686039,0.0001939566,0.00008915592,0.00001856544,0.0003709462,0.0009690405,0.00006045216,0.0007371801,0.00001659441],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9898748,0.001682398,0.0008171226,0.0004965334,0.0002083197,0.004870949,0.00083904,0.000126669,0.001084191],"genre_scores_gemma":[0.9826398,0.002156548,0.002892316,0.0009973113,0.0003876328,0.006003703,0.001820582,0.00003992541,0.003062326],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005141045,"threshold_uncertainty_score":0.0171985,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08095083295401598,"score_gpt":0.4213288046548228,"score_spread":0.3403779717008069,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}